MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from partner
companies' equity...
$61,621K
Proceeds from partner
companies' at-the-market...
$19,052K
Net cash increase
upon...
$8,956K
Proceeds from sale of
property and equipment
$1,165K
Exercise of warrants for
cash
$2,647K
Proceeds from issuance of
common stock for...
$1,008K
Proceeds from partner
companies' espp
$217K
Proceeds from issuance of
common stock under espp
$87K
Net cash provided by
financing activities
$77,442K
Net cash provided by
(used in) investing...
$10,121K
Canceled cashflow
$7,190K
Net increase
(decrease) in cash and cash...
$21,786K
Canceled cashflow
$65,777K
Repayment of oaktree note
and debt issuance...
$5,561K
Partner company's
dividends declared and...
$664K
Repayment of partner
company installment...
$625K
Partner company's
redemption of preferred...
$265K
Proceeds from long-term
debt, net
-$75K
Stock-based compensation
expense
$28,739K
Inventory
-$4,807K
Amortization of acquired
intangible assets
$4,258K
Reduction in the carrying
amount of operating...
$1,943K
Prepaid expenses and
other current assets
-$1,546K
Amortization of debt discount
$1,404K
Depreciation expense
$403K
Change in fair value of
partner companies'...
$398K
Other assets
-$330K
Other receivables -
related party
-$13K
Net cash used in
operating activities
-$65,777K
Canceled cashflow
$43,841K
Net income (loss)
-$32,915K
Gain from
deconsolidation of subsidiary
$27,127K
Accounts receivable
$19,341K
Change in fair value of
investment
$15,075K
Accounts payable and
accrued expenses
-$7,971K
Lease liabilities
-$2,226K
Settlement of partner
company payables
-$2,104K
Other liabilities
-$1,678K
Income taxes payable
-$576K
Gain on termination
of partner company...
$394K
Bad debt (recovery)
expense
-$211K
Back
Back
Cash Flow
source: myfinsight.com
Fortress Biotech, Inc. (FBIO)
Fortress Biotech, Inc. (FBIO)